Topics

Articles

Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar gaps, reimbursement pressure from GLP-1s, and persistent access challenges.

Asembia 2025: Rare Disease Therapies Drive Shift in Drug Development Focus

. He can be reached at nsaraceno@mjhlifesciences.com.

Podcasts

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework. 

Fast-Tracking the Future

By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.

Innovation with GenAI: Lessons from Life Sciences and Beyond

Director of Project Services & Logistics at Almac Pharma Services.

Exploring the importance of contract development and manufacturing organizations in advancing the latest technology for effective delivery of temperature-sensitive medicines.

The Role of CDMOs in the Pharma Cold Chain Machine

Videos

Steffen Lang, president, operations, executive committee member, Novartis, discusses what to expect from Novartis over the next decade in terms of technological innovations. 

LogiPharma Europe 2025: Driving Innovation in Core Therapeutic Areas

How can stakeholders prepare for changing therapy requirements?  

LogiPharma Europe 2025: Reevaluating One’s CGT Value Chain

A keynote presentation describes how supply chain visibility should rely on digital capabilities. 

LogiPharma Europe 2025: Being a Part of an AI-Powered E2E Supply Chain

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief medical officer, shares his thoughts on the rumors that RFK Jr. could potentially ban DTC advertising.

A Change in Healthcare Education and Provider Awareness

Director of Global Healthcare & Life Sciences Industry Strategy at Google Cloud.

Taking stock of today's gains and tomorrow's potential for generative artificial intelligence in reshaping the industry.

Beyond the Hype: GenAI’s Real Impact on Life Sciences Manufacturing

The parties aim to create an end-to-end digital thread that links research data all the way through to life sciences manufacturing.

Data & Technology